Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
5/17/24 18:42 | 5/17/24 | SCLX | Health | BioPrd | Biological Products, (No Diag | Ji Henry | CA | DO | Exec Cha | P | 44 | 0.8797 | 0 | 50 | 8 | 656 | I | ||||||||||||||
5/17/24 18:41 | 5/17/24 | SCLX | Health | BioPrd | Biological Products, (No Diag | Chun Jay | CA | D | P | 52 | 0.8981 | 0 | 58 | 128 | 103 | D | |||||||||||||||
5/17/24 17:36 | 5/16/24 | SCLX | Health | BioPrd | Biological Products, (No Diag | Shah Jaisim | CA | DO | See Rema | P.m | 122 | 0.8710 | 0 | 140 | 882 | 156 | I | ||||||||||||||
5/17/24 16:29 | 5/17/24 | SCLX | Health | BioPrd | Biological Products, (No Diag | Ma Stephen Hoi | CA | O | CFO | P | 12 | 0.8800 | 0 | 14 | New | 14 | D | ||||||||||||||
9/25/23 16:27 | 9/21/23 | SCLX | Health | BioPrd | Biological Products, (No Diag | Sorrento Therapeutics, Inc. | CA | T | S.d | 0 | 0.00 | 0 | -60,069 | -97 | 1,917 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |